ArticleScientific reports2024
Evidence for disrupted copper availability in human spinal cord supports Cu
Open access · goldAbstract read
In one paragraph
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 36 citations in OpenAlex.
- Trace Elements Dyshomeostasis and Toxic Metals Neurotoxicity in Neurodegenerative Diseases.Biological trace element research · 2026Review
- Review
- Emerging role of copper in the pathophysiology of spinal cord injury.Neural regeneration research · 2026Article
- Exploring and Targeting the Connection of Iron and Copper Homeostasis to Neurodegenerative Diseases.MedComm · 2026Review
- Top-Down Mass Spectrometry and Its Current Applications in Biomarker Discovery in Aging and Age-Related Diseases.International journal of molecular sciences · 2026Review
- Decreased metallothionein-3 expression in the human spinal cord is a common feature of amyotrophic lateral sclerosis and multiple sclerosis.Scientific reports · 2026Article
- Oxidative denaturation of Cu/Zn-superoxide dismutase associated with neurodegenerative diseases.Protein science : a publication of the Protein Society · 2025Article
- Copper regulates the expression of immune genes in microglial cells in vitro.Immunobiology · 2025Article
- Imaging Copper Levels during Life in the Brain and beyond Using a Fluorescent Copper Sensor with Multimodal Capacity.Chemical & biomedical imaging · 2025Article
- Use of Proteomics to Explore Biomarkers of Amyotrophic Lateral Sclerosis (ALS): Proof of Principle from Humanized SOD1 Mouse to Human ALS.ACS pharmacology & translational science · 2025Review
- Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model.Acta neuropathologica communications · 2025Article
- Metal-Induced Genotoxic Events: Possible Distinction Between Sporadic and Familial ALS.Toxics · 2025Review
- Urolithin a Improves Motor Dysfunction Induced by Copper Exposure in SOD1Molecular neurobiology · 2025Article
- Emerging Ferroptosis Involvement in Amyotrophic Lateral Sclerosis Pathogenesis: Neuroprotective Activity of Polyphenols.Molecules (Basel, Switzerland) · 2025Review
- Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model.Acta neuropathologica · 2025Article
- Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.Signal transduction and targeted therapy · 2025Review
- From copper homeostasis to cuproptosis: a new perspective on CNS immune regulation and neurodegenerative diseases.Frontiers in neurology · 2025Review
- Discovery of Novel Inhibitors against ALS-Related SOD1(A4V) Aggregation through the Screening of a Chemical Library Using Differential Scanning Fluorimetry (DSF).Pharmaceuticals (Basel, Switzerland) · 2024Article
- Decreased spinal cord motor neuron numbers in mice depleted of central nervous system copper.Metallomics : integrated biometal science · 2024Article
- Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 6 institutions in 2 countries.
James B W HiltonDepartment of Anatomy and Physiology, The University of Melbourne, Victoria, 3010, Australia.ORCID http://orcid.org/0000-0002-2657-3566
Kai KyseniusDepartment of Anatomy and Physiology, The University of Melbourne, Victoria, 3010, Australia.
Jeffrey R LiddellDepartment of Anatomy and Physiology, The University of Melbourne, Victoria, 3010, Australia.ORCID http://orcid.org/0000-0002-0798-5338
Stephen W MercerDepartment of Anatomy and Physiology, The University of Melbourne, Victoria, 3010, Australia.
Bence PaulSchool of Geography, Earth and Atmospheric Sciences, The University of Melbourne, Victoria, 3010, Australia.
Joseph S BeckmanLinus Pauling Institute and Department of Biochemistry and Biophysics, Oregon State University, Corvallis, OR, 97331, USA.
Catriona A McLeanDepartment of Anatomical Pathology, The Alfred Hospital, Victoria, 3004, Australia.
Anthony R WhiteMental Health Program, Department of Cell and Molecular Biology, Queensland Institute of Biomedical Research Berghofer, Herston, QLD, 4006, Australia.
Paul S DonnellySchool of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria, 3010, Australia.
Ashley I BushMelbourne Dementia Research Centre, The University of Melbourne and Florey Institute of Neuroscience and Mental Health, Victoria, 3010, Australia.
Dominic J HareAtomic Medicine Initiative, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
Blaine R RobertsDepartment of Biochemistry, Emory University School of Medicine, Atlanta, GA, 30322, USA.
Peter J CrouchDepartment of Anatomy and Physiology, The University of Melbourne, Victoria, 3010, Australia. pjcrouch@unimelb.edu.au.ORCID http://orcid.org/0000-0002-7777-4747
The University of Melbourne · AUEmory University · USOregon State University · USQIMR Berghofer Medical Research Institute · AUThe Alfred Hospital · AUUniversity of Technology Sydney · AU
Funding
No grant is acknowledged in the PubMed record.
Abstract
The copper compound Cu
Indexed as
Amyotrophic Lateral SclerosisCoordination ComplexesNeurodegenerative DiseasesThiosemicarbazonesAnimalsCeruloplasminCopperDisease Models, AnimalHumansMiceMice, TransgenicSpinal CordSuperoxide DismutaseSuperoxide Dismutase-1CeruloplasminCoordination ComplexesCoppercopper (II) diacetyl-di(N(4)-methylthiosemicarbazone)Superoxide DismutaseSuperoxide Dismutase-1Thiosemicarbazones
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.